Immune Privilege Collapse and Alopecia Development: Is Stress a Factor

Skin Appendage Disorders

Volumn 4, Issue 4, 2018, Pages 236-244

  Azzawi, Soraya ^a   Penzi, Lauren R ^b   Senna, Maryanne M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alopecia areata; Autoimmune alopecia; Hair follicle immune privilege; Lichen planopilaris; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; SUBSTANCE P;

ALOPECIA; ALOPECIA AREATA; AUTOIMMUNE DISEASE; EMOTIONAL STRESS; HAIR FOLLICLE; HAIR LOSS; HUMAN; IMMUNE PRIVILEGE; LICHEN (DISEASE); LICHEN PLANOPILARIS; MAST CELL DEGRANULATION; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 85053702822     PISSN: 22969195     EISSN: 22969160     Source Type: Journal    
DOI: 10.1159/000485080     Document Type: Review

References (131)

1. Sperling LC: Hair anatomy for the clinician. J Am Acad Dermatol 1991;25:1-17.
2. Harries MJ: The immunopathobiology of lichen planopilaris; PhD thesis. Manchester, University of Manchester, 2011.
3. Harries MJ, Paus R: The pathogenesis of primary cicatricial alopecias. Am J Pathol 2010;177:2152-2162.
4. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999;341:491-497.
5. Schneider MR, Schmidt-Ullrich R, Paus R: The hair follicle as a dynamic miniorgan. Curr Biol 2009;19:R132-R142.
6. Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, Meyer W, Sinclair R, Paus R: Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008;159:1077-1085.
7. Harries MJ, Trueb RM, Tosti A, Messenger AG, Chaudhry I, Whiting DA, Sinclair R, Griffiths CE, Paus R: How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol 2009;160:482-501.
8. Ross EK, Tan E, Shapiro J: Update on primary cicatricial alopecias. J Am Acad Dermatol 2005;53:1-37.
9. Kang H, Alzolibani AA, Otberg N, Shapiro J: Lichen planopilaris. Dermatol Ther 2008;21:249-256.
10. Soares VC, Mulinari-Brenner F, Souza TE: Lichen planopilaris epidemiology: a retrospective study of 80 cases. An Bras Dermatol 2015;90:666-670.
11. Meinhard J, Stroux A, Lünnemann L, Vogt A, Blume-Peytavi U: Lichen planopilaris: epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients. J Dtsch Dermatol Ges 2014;12:229-235, 229-236.
12. Handa S, Sahoo B: Childhood lichen planus: a study of 87 cases. Int J Dermatol 2002;41:423-427.
13. Gilhar A, Paus R, Kalish RS: Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007;117:2019-2027.
14. Messenger AG, Slater DN, Bleehen SS: Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol 1986;114:337-347.
15. Villasante Fricke AC, Miteva M: Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol 2015;8:397-403.
16. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd: Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70:628-633.
17. Harries MJ, Meyer KC, Chaudhry IH, Griffiths CE, Paus R: Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermal 2010;35:637-644.
18. Niederkorn JY: See no evil, hear no evil, do no evil: the lessons of immuneprivilege. Nat Immunol 2006;7:354-359.
19. Hong S, Van Kaer L: Immune privilege: keeping an eye on natural killer T cells. J Exp Med 1999;190:1197-1200.
20. Streilein JW, Ksander BR, Taylor AW: Immune deviation in relation to ocular immune privilege. J Immunol 1997;158:3557-3560.
21. Streilein JW, Takeuchi M, Taylor AW: Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol 1997;52:138-143.
22. Ferguson TA, Griffith TS: A vision of cell death: insights into immune privilege. Immunol Rev 1997;156:167-184.
23. Paus R, Ito N, Takigawa M, Ito T: The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003;8:188-194.
24. Billingham RE: Transplantation immunity evoked by skin allografts and expressed in intact skin; in Montagna W, Billingham RE (eds): Immunology of the Skin. Adv Biol Skin. New York, Appleton-Century-Crofts, 1971, vol XI, pp 183-198.
25. Billingham RE, Silvers WK: A biologist's reflections on dermatology. J Invest Dermatol 1971;57:227-240.
26. Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001;81:449-494.
27. Westgate GE, Craggs RI, Gibson WT: Immune privilege in hair growth. J Invest Dermatol 1991;97:417-420.
28. Christoph T, Müller-Röver S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Rückert R, Paus R: The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000;142:862-873.
29. Bröcker EB, Echternacht-Happle K, Hamm H, Happle R: Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987;88:564-568.
30. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R: Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004;164, 623-634.
31. Prasanna SJ, Nandi D: The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression: roles of TAP, Tapasin and beta2-microglobulin. Mol Immunol 2004;41:1029-1045.
32. Paus R, Eichmüller S, Hofmann U, Czarnetzki BM, Robinson P: Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol 1994;131:177-183.
33. Rückert R, Hofmann U, van der Veen C, Bulfone-Paus S, Paus R: MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998;111:25-30.
34. Moseley RP, Brown JI, Auld J, Mumtaz H, Rainey AJ, Kirkham N, Gelsthorpe K, Masters R, Smith ME: An immunohistochemical study of MHC class I expression on human Langerhans cells and melanocytes. J Pathol 1997;181:419-425.
35. Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, Nickoloff BJ, Takigawa M, Paus R: Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermal 2008;128:1196-1206.
36. Bröcker EB, Echternacht-Happle K, Hamm H, Happle R: Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987;88:564-568.
37. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
38. Ito T: Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci 2010;60:67-73.
39. Cerwenka A, Swain SL: TGF-beta1: immunosuppressant and viability factor for T lymphocytes. Microbes Infect 1999;1:1291-1296.
40. Wahl SM, Wen J, Moutsopoulos N: TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 2006;213:213-227.
41. Foitzik K, Lindner G, Mueller-Roever S, Maurer M, Botchkareva N, Botchkarev V, Handjiski B, Metz M, Hibino T, Soma T, Dotto GP, Paus R: Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J 2000;14:752-760.
42. Paus R, Nickoloff BJ, Ito T: A "hairy" privilege. Trends Immunol 2005;26:32-40.
43. Gilhar A, Kalish RS: Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006;5:64-69.
44. Nishimura EK, Suzuki M, Igras V, Du J, Lonning S, Miyachi Y, Roes J, Beermann F, Fisher DE: Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell 2010;6:130-140.
45. Tanimura S, Tadokoro Y, Inomata K, Binh NT, Nishie W, Yamazaki S, Nakauchi H, Tanaka Y, McMillan JR, Sawamura D, Yancey K, Shimizu H, Nishimura EK: Hair follicle stem cells provide a functional niche for melanocyte stem cells. Cell Stem Cell 2011;8:177-187.
46. Slominski A, Wortsman J, Mazurkiewicz JE, Matsuoka L, Dietrich J, Lawrence K, Gorbani A, Paus R: Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993;122:658-666.
47. Slominski A, Botchkareva NV, Botchkarev VA, Chakraborty A, Luger T, Uenalan M, Paus R: Hair cycle-dependent production of ACTH in mouse skin. Biochim Biophys Acta 1998;1448:147-152.
48. Slominski A, Wortsman J, Luger T, Paus R, Solomon S: Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020.
49. Slominski A, Paus R, Mazurkiewicz J: Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 1992;48:50-54.
50. Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D, Eastman A: The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1996;1289:247-251.
51. Slominski A, Botchkareva NV, Botchkarev VA, Chakraborty A, Luger T, Uenalan M, Paus R: ACTH production in C57BL/6 mouse skin. Ann NY Acad Sci 1999;885:448-450.
52. Paus R, Botchkarev VA, Botchkareva NV, Mecklenburg L, Luger T, Slominski A: The skin POMC system (SPS). Leads and lessons from the hair follicle. Ann NY Acad Sci 1999;885:350-363.
53. Slominski A, Heasley D, Mazurkiewicz JE, Ermak G, Baker J, Carlson JA: Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol 1999;30:208-215.
54. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R: Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann NY Acad Sci 1998;840:381-394.
55. Luger TA, Scholzen TE, Brzoska T, Böhm M: New insights into the functions of alpha-MSH and related peptides in the immune system. Ann NY Acad Sci 2003;994:133-140.
56. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY: Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998;160:5693-5696.
57. Arcuri F, Cintorino M, Carducci A, Papa S, Riparbelli MG, Mangioni S, Di Blasio AM, Tosi P, Viganò P: Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 2006;131:175-182.
58. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC: Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006;116:249-260.
59. Barclay AN, Wright GJ, Brooke G, Brown MH: CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002;23:285-290.
60. Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL: Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol 2004;123:880-887.
61. Rosenblum MD, Yancey KB, Olasz EB, Truitt RL: CD200, a "no danger" signal for hair follicles. J Dermatol Sci 2006;41:165-174.
62. Apte RS, Niederkorn JY: Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 1996;156:2667-2673.
63. Harries MJ, Meyer K, Chaudhry I, E Kloepper J, Poblet E, Griffiths CE, Paus R: Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. J Pathol 2013;231:236-247.
64. Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993;66:541-554.
65. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, et al. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 2006;155:515-521.
66. Cotsarelis G: Gene expression profiling gets to the root of human hair follicle stem cells. J Clin Invest 2006;116:19-22.
67. Tiede S, Koop N, Kloepper JE, Fässler R, Paus R: Nonviral in situ green fluorescent protein labeling and culture of primary, adult human hair follicle epithelial progenitor cells. Stem Cells 2009;27:2793-2803.
68. Stelekati E, Bahri R, D'Orlando O, Orinska Z, Mittrücker HW, Langenhaun R, Glatzel M, Bollinger A, Paus R, Bulfone-Paus S: Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009;31:665-676.
69. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T: Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93:12445-12450.
70. Yamamoto K, Fujiyama Y, Andoh A, Bamba T, Okabe H: Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim Biophys Acta 2001;1526:10-12.
71. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
72. Carosella ED, Rouas-Freiss N, Paul P, Dausset J: HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol Today 1999;20:60-62.
73. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285:730-732.
74. Menier C, Riteau B, Carosella ED, Rouas-Freiss N: MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 2002;100:63-70.
75. Middleton D, Curran M, Maxwell L: Natural killer cells and their receptors. Transpl Immunol 2002;10:147-164.
76. Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A: Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002;62:6178-6186.
77. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T: Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 2003;100:9452-9457.
78. Caillat-Zucman S: How NKG2D ligands trigger autoimmunity? Hum Immunol 2006;67:204-207.
79. Jie HB, Sarvetnick N: The role of NK cells and NK cell receptors in autoimmune disease. Autoimmunity 2004;37:147-153.
80. Shoenfeld Y, Isenberg DA: The mosaic of autoimmunity. Immunol Today 1989;10:123-126.
81. Brickman CM, Shoenfeld Y: The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl 2001;235:3-15.
82. Herrmann M, Schölmerich J, Straub RH: Stress and rheumatic diseases. Rheum Dis Clin North Am 2000;26:737-763.
83. Stojanovich L: Stress and autoimmunity. Autoimmun Rev 2010;9:A271-A276.
84. Shepshelovich D, Shoenfeld Y: Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 2006;15:183-190.
85. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B: Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA 2006;103:678-83.
86. Brauner GJ, Goodheart HP: Dermatologic care behind bars. J Am Acad Dermatol 1988;18:1066-1073.
87. Muller SA, Winkelmann RK: Alopecia areata: an evaluation of 736 patients. Arch Dermatol 1963;88:290-297.
88. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
89. García-Hernández MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F: Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999;26:625-632.
90. Inui S, Nakajima T, Itami S: Two cases of alopecia areata responsive to fexofenadine. J Dermatol 2007;34:852-854.
91. Kakourou T, Karachristou K, Chrousos G: A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol 2007;21:356-359.
92. Hampf BG, Malmström MJ, Aalberg VA, Hannula JA, Vikkula J: Psychiatric disturbance in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1987;63:429-432.
93. Kaplan B, Barnes L: Oral lichen planus and squamous carcinoma. Case report and update of the literature. Arch Otolaryngol 1985;111:543-547.
94. Lowental U, Pisanti S: Oral lichen planus according to the modern medical model. J Oral Med 1984;39:224-226.
95. Boyd AS, Neldner KH: Lichen planus. J Am Acad Dermatol 1991;25:593-619.
96. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R: Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005;19:1332-1334.
97. Arck PC, Handjiski B, Peters EM, Peter AS, Hagen E, Fischer A, Klapp BF, Paus R: Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003;162:803-814.
98. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, Bulfone-Paus S, Zipper J, Krause E, Paus R: Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 1998;12:287-297.
99. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J: Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 2004;145:941-950.
100. Ito N, Ito T, Betterman A, Paus R: The human hair bulb is a source and target of CRH. J Invest Dermal 2004;122:235-237.
101. Ito N, Sugawara K, Bodó E, Takigawa M, van Beek N, Ito T, Paus R: Corticotropin-releasing hormone stimulates the in-situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010;130:995-1004.
102. Maurer M, Echtenacher B, Hültner L, Kollias G, Männel DN, Langley KE, Galli SJ: The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998;188:2343-2348.
103. Weber A, Knop J, Maurer M: Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol 2003;148:224-228.
104. Theoharides TC, Cochrane DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12.
105. Arck PC, Handjiski B, Kuhlmei A, Peters EM, Knackstedt M, Peter A, Hunt SP, Klapp BF, Paus R: Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl) 2005;83:386-396.
106. Maurer M, Metz M: The status quo and quo vadis of mast cells. Exp Dermatol 2005;14:923-929.
107. Weller K, Foitzik K, Paus R, Syska W, Maurer M: Mast cells are required for normal healing of skin wounds in mice. FASEB J 2006;20:2366-2368.
108. Metz M, Maurer M: Mast cells-key effector cells in immune responses. Trends Immunol 2007;28:234-241.
109. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R: Indications for a "brain-hair follicle axis (BHA)": inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001;15:2536-2538.
110. Theoharides TC, Singh LK, Boucher W, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998;139:403-413.
111. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P: Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004;25:563-568.
112. Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol 2003;12:886-910.
113. Aloe L, Alleva E, Böhm A, Levi-Montalcini R: Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci USA 1986;83:6184-6187.
114. Aloe L, Alleva E, De Simone R: Changes of NGF level in mouse hypothalamus following intermale aggressive behaviour: biological and immunohistochemical evidence. Behav Brain Res 1990;39:53-61.
115. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN: Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990;85:1085-1089.
116. Paus R, Luftl M, Czarnetzki BM: Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 1994;130:174-180.
117. Botchkarev VA, Welker P, Albers KM, et al. A new role for neurotrophin-3:involvement in the regulation of hair follicle regression (catagen). Am J Pathol 1998;153:785-799.
118. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383:716-719.
119. Frade JM, Rodriguez Tebar A, Barde YA: Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996;383:166-168.
120. Yaar M, Zhai S, Pilch PF, et al. Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis: a possible mechanism for Alzheimer's disease. J Clin Invest 1997;100:2333-2340.
121. Peters EM, Handjiski B, Kuhlmei A, Hagen E, Bielas H, Braun A, Klapp BF, Paus R, Arck PC: Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004;165:259-271.
122. Botchkareva NV, Botchkarev VA, Chen LH, Lindner G, Paus R: A role for p75 neurotrophin receptor in the control of hair follicle morphogenesis. Dev Biol 1999;216:135-153.
123. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J: Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999;162:4271-4276.
124. Peters EM, Liotiri S, Bodó E, Hagen E, Bíró T, Arck PC, Paus R: Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 2007;171:1872-1886.
125. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC: Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999;13:225-239.
126. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC: Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81-96.
127. Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-4485.
128. Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R: Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 1996;288:153-156.
129. Bläsing H, Hendrix S, Paus R: Pro-inflammatory cytokines upregulate the skin immunoreactivity for NGF, NT-3, NT-4 and their receptor, p75NTR in vivo: a preliminary report. Arch Dermatol Res 2005;296:580-584.
130. Tong X, Coulombe PA: Keratin 17 modulates hair follicle cycling in a TNF alpha-dependent fashion. Genes Dev 2006;20:1353-1364.
131. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R: Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006;126:1697-1704.